Emerg Infect Dis. 2024 Sep;30(9):1819-1828. doi: 10.3201/eid3009.240372. Epub 2024 Aug 6.
During 2018-2021, eight septic transfusion reactions occurred from transfusion of platelet units contaminated with Acinetobacter spp., Staphylococcus saprophyticus, Leclercia adecarboxylata, or a combination of those environmental organisms. Whether biofilm formation contributed to evasion of bacterial risk mitigations, including bacterial culture, point-of-care testing, or pathogen-reduction technology, is unclear. We designed a 12-well plate-based method to evaluate environmental determinants of single-species and multispecies biofilm formation in platelets. We evaluated bacteria isolated from septic transfusion reactions for biofilm formation by using crystal violet staining and enumeration of adherent bacteria. Most combinations of bacteria had enhanced biofilm production compared with single bacteria. Combinations involving L. adecarboxylata had increased crystal violet biofilm production and adherent bacteria. This study demonstrates that transfusion-relevant bacteria can produce biofilms well together. More work is needed to clarify the effect of biofilms on platelet bacterial risk control strategies, but US Food and Drug Administration-recommended strategies remain acceptable.
在 2018 年至 2021 年期间,有 8 例因输注受不动杆菌属、腐生葡萄球菌、去羧莱氏菌属污染的血小板单位而发生的败血症输血反应,或这些环境生物的组合。生物膜形成是否有助于逃避包括细菌培养、即时检测或病原体减少技术在内的细菌风险缓解措施尚不清楚。我们设计了一种基于 12 孔板的方法来评估血小板中单种和多种生物膜形成的环境决定因素。我们通过结晶紫染色和附着细菌的计数来评估从败血症输血反应中分离出的细菌的生物膜形成情况。与单一细菌相比,大多数细菌组合的生物膜生成能力增强。涉及去羧莱氏菌属的组合增加了结晶紫生物膜的生成和附着的细菌。本研究表明,与输血相关的细菌可以很好地形成生物膜。需要进一步研究以阐明生物膜对血小板细菌风险控制策略的影响,但美国食品和药物管理局推荐的策略仍然是可以接受的。